课题基金 / 基金详情

Anti-melanoma Activity of Combined Lymphopenia and Immunotherapy

Anti-melanoma Activity of Combined Lymphopenia and Immunotherapy
淋巴细胞减少症和免疫疗法联合治疗的抗黑色素瘤活性
批准号：
8142911
负责人：
Shari Pilon-Thomas
金额：
$24.15万
依托单位：
H. LEE MOFFITT CANCER CTR & RES INST
依托单位国家：
美国
项目类别：
财政年份：
2010
资助国家：
美国
项目状态：
已结题
起止时间：
2010-09-14 至 2013-08-31
来源：
https://reporter.nih.gov/project-details/8142911
关键词：
Adjuvant TherapyAdoptive TransferAntigen-Presenting CellsApoptoticBone MarrowCancer PatientCell Surface ReceptorsCellsClinicalCombined Modality TherapyDendritic Cell TherapyDendritic CellsDetectionDevelopmentGuanine Nucleotide Dissociation InhibitorsHumanIL2RA geneITGAM geneIgG ReceptorsImmuneImmune systemImmunityImmunizationImmunologic AdjuvantsImmunotherapeutic agentImmunotherapyInstructionLeadLymphopeniaMediatingMemoryModelingMusMyeloid CellsNeoadjuvant TherapyPatientsPeptidesPhysiologic pulsePopulationPrimary NeoplasmRegulationRegulatory T-LymphocyteResearchT cell responseT memory cellT-LymphocyteTranslationsTumor ImmunityVaccinationWhole-Body Irradiationbasecancer therapydesignimprovedinnovationirradiationmelanomaneoplastic cellperipheral bloodpre-clinicalreconstitutionresearch studytumortumor growth

项目成果

Shari Pilon-Thomas的其他基金

相似基金

相关文献

期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mathematical Model-Guided Adoptive Immunotherapy in Bladder Cancer
Mathematical Model-Guided Adoptive Immunotherapy in Bladder Cancer
Mathematical Model-Guided Adoptive Immunotherapy in Bladder Cancer
Anti-melanoma Activity of Combined Lymphopenia and Immunotherapy
海外基金